Opportunities in Indian Pharma Sector

Published by: RNCOS

Published: Jul. 1, 2006 - 70 Pages

Table of Contents

1. Analyst View

2. Industry Overview

2.1 World Overview of Pharmaceutical Industry

2.2 India’s Position in the Global Industry

3. Pharmaceutical Industry Performance

3.1 Production of Bulk Drugs and Formulations

3.2 Export and Import Trends in Pharmaceutical Industry

3.3 Emerging Trends

3.3.1 Contract Manufacturing

3.3.2 Research & Development

3.3.3 Clinical Trials

3.3.4 Bio Pharmaceuticals

4. Analysis of Regulatory Frameworks and Policies Initiated in Industry Growth

4.1 Indian Patent Law

4.2 Drugs Price Control Order (DPCO)

4.3 National Pharmaceutical Pricing Authority (NPPA)

5. Key Drivers of Pharmaceutical Industry

6. Opportunities and Threats

6.1 Opportunities

6.2 Threats

7. Mergers and Consolidations in Indian Pharmaceutical Sector

8. Recent News & Industry Developments

9. Key Players in Pharmaceuticals Industry

9.1 Cadila Healthcare Ltd.

9.2 Cipla Ltd.

9.3 Ranbaxy Laboratories Ltd.

9.4 Dr Reddy's Laboratories Ltd.

9.5 Nicholas Piramal India Ltd.

9.6 Wockhardt Ltd.

9.7 GlaxoSmithkline Pharmaceuticals Ltd.

9.8 Pfizer Ltd.

List of Figures:

Figure 2-1: World - Pharmaceutical Market Revenue (in Billion US$), 2001-2005

Figure 2-2: World - Pharmaceutical Market Segment by Geographical Region (%), 2005

Figure 2-3: World - Pharmaceutical Market by Therapeutic Segmentation (%), 2004

Figure 2-4: India - Growth in the Pharmaceutical Industry Market (in Billion US$), 2005-2010F

Figure 3-1: India - Bulk Drugs and Formulations Export Trends (in Rs Crore), 1994-95 to 2003-04

Figure 3-2: India - Bulk Drugs, Formulations & Intermediate Import Trends (in Rs Crore), 1994-95 to 2004-05

Figure 3-3: World - Forecast for Contract Manufacturing and Research Services (in Billion US$), 2005-2009

Figure 3-4: India - R&D Investment in the Pharmaceuticals Industry (in Million US$), 1993-94 to 2000-01

Figure 3-5: India - R&D Expenditure by Company (in Million US$), 2004-05

Figure 3-6: India - Biotechnology Market Composition (%), 2004-05

Figure 5-1: India - Population (in Million), 2001-2005

Figure 5-2: India - Growth in Real GDP (%), 2000-2005

Figure 5-3: India - Real Personal Disposable Income (in Billion US$), 2000-2005

Figure 5-4: India - Per Capita Income (in Rs), 2002-2004

Figure 5-5: India - Urban Population (in Million), 2001-2005

Figure 5-6: India - Growth in Urban Population (%), 2001-2005

Figure 5-7: India - Number of Cardiac Disease Related Treatments (in Million), 2004-2008F

Figure 5-8: India - Rise in % of Population Aged 65 years and above (2000-2005)

Figure 6-1: India - Contract Research Market (in Billion US$), 2004-2008F

Figure 9-1: Cadila Healthcare Ltd. - Stock Performance

Figure 9-2: Cipla Ltd. - Stock Performance

Figure 9-3: Ranbaxy Laboratories Ltd. - Stock Performance

Figure 9-4: Dr. Reddy's Laboratories Ltd. - Stock Performance

Figure 9-5: Nicholas Piramal India Ltd. - Stock Performance

Figure 9-6: Wockhardt Ltd. - Stock Performance

Figure 9-7: GlaxoSmithkline Pharmaceuticals Ltd. - Stock Performance

Figure 9-8: Pfizer Ltd. - Stock Performance

List of Tables:

Table 2-1: India - Pharmaceutical Industry, 2004

Table 2-2: India - Major Therapeutic Segments, 2004

Table 3-1: India - Bulk Drug & Formulations Production (1994-2004)

Table 3-2: India - Pharmaceuticals Market Export (in Rs Crore), 1994-95 to 2003-04

Table 3-3: India - Pharmaceuticals Market Imports (in Rs Crore), 1994-95 to 2004-05

Table 3-4: Contract Manufacturing Deals (in Million US$), 2004

Table 6-1: India - ANDA Filing by Mid-size Companies (FY 2004 to FY 2006)

Table 6-2: India - R&D Agreements with Foreign Partners

Table 9-1: Cadila Healthcare Ltd. - Ratio Analysis (2003-2005)

Table 9-2: Cadila Healthcare Ltd. - Financial Overview, 2005

Table 9-3: Cadila Healthcare Ltd. - Top Management

Table 9-4: Cipla Ltd. - Ratio Analysis (2003-2005)

Table 9-5: Cipla Ltd. - Financial Overview (in US$), 2004-2006

Table 9-6: Cipla Ltd. - Top Management

Table 9-7: Ranbaxy Laboratories Ltd. - Ratio Analysis (2002-2004)

Table 9-8: Ranbaxy Laboratories Ltd. - Financial Overview (in US$), 2003-2005

Table 9-9: Ranbaxy Laboratories Ltd. - Top Management

Table 9-10: Dr. Reddy's Laboratories Ltd. - Financial Overview (2003-2005)

Table 9-11: Dr. Reddy's Laboratories Ltd. - Top Management

Table 9-12: Nicholas Piramal India Ltd. - Ratio Analysis (2003-2005)

Table 9-13: Nicholas Piramal India Ltd. - Financial Overview (in US$), 2004-2006

Table 9-14: Nicholas Piramal India Ltd. - Top Management

Table 9-15: Wockhardt Ltd. - Ratio Analysis (2003 & 2004)

Table 9-16: Wockhardt Ltd. - Financial Overview (in US$), 2003-2005

Table 9-17: Wockhardt Ltd. - Top Management

Table 9-18: GlaxoSmithkline Pharmaceuticals Ltd. - Ratio Analysis (2002-2004)

Table 9-19: GlaxoSmithkline Pharmaceuticals Ltd. - Financial Overview (in US$), 2003-2005

Table 9-20: GlaxoSmithkline Pharmaceuticals Ltd. - Top Management

Table 9-21: Pfizer Ltd. - Key Financial Information (in Lakh Rs), 2004 & 2005

Table 9-22: Pfizer Ltd. - Top Management

Abstract

• India currently holds US$ six Billion of the $550 Billion global pharmaceutical industry; its share is increasing at 10% a year. As compared 7% annual growth for the overall world markets, this figure speaks of a very promising scenario.
• Domestic pharmaceutical companies will increasingly be looking for consolidation across the value chain by forming partnerships or mergers with companies of complementary strengths. As drug discovery becomes more expensive, and the costs of administration and regulatory compliance continuously rise, these partnerships will become more central to Pharma companies' business proposition.
• The Bio Pharmaceutical market is seeing a consistent growth trend since 2004, which saw record vaccine sales of US$ 386.3 Million and Marketing licenses being granted for over 25 recombinant therapeutic protein. The Diagnostics market size stands for US$138.2 Million.

• Emerging trends in the Pharmaceutical sector in India
• Key regulations and the policy environment in the industry
• Future prospects of the Pharmaceutical industry in India
• Key players in the Pharmaceutical market in India
• Opportunities and challenges in the Pharmaceutical market
• Effect of other factors prevailing in the economy on the Indian Pharmaceutical market

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.